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Abstract
CD4+ T cells play a critical role in the immune system and protecting the body
from infection. Cell differentiation of T-cells leads to the specialization of the immune
system and has been determined to have plasticity. Differentiation of the CD4+ T cells
depends on cytokines present in the environment, concentration of antigens, types of
antigen – presenting cells (APCs), and costimulatory molecules (Luckheeram, 2012).
Commonly known differentiated T-cells include the T-helper 1 (Th1) and the T-helper 2
(Th2) cells. Upon CD4+ T cell activation, the cells undergo metabolic changes that allow
for cell growth and division. By characterizing the metabolic network of these cells, we
gain a better understanding of metabolic processes that are characteristic of each cell
type. Expression data was gathered and used to identify essential genes within the
differentiated cells. With statistical analysis of these cell’s gene expression and
regulation, we can more fully understand each gene that plays a role in the
differentiation of the naïve cell. Specifically, I will focus on the differentiation of Th2 cells
from the naïve CD4+ T cell. With computational modeling, the metabolic network of Th2
cells was built.

Key Words: T-helper 2 Cell, CD4+ T Cells, Metabolic Network Model, Constraint-Based
Modeling, Flux Balance Analysis, Biochemistry
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Introduction
CD4+T cells
The immune system is critical for the body to fight off pathogens and protect the
body from disease. It is comprised of lymphocytes, which allow these functions to be
carried out (Janeway, 2001). More specifically, T- lymphocytes mature in the thymus
gland and are designed to send out signals to other cells to localize and eradicate a
foreign pathogen (Janeway, 2001). T – lymphocytes consist mainly of CD4+T and
CD8+T cells. CD4+ T cells function in recognition and elimination of foreign antigens,
formation of immunologic memory, and development of tolerance to self-antigens
(Luckheeram, 2012). Upon activation, CD4+ T cells can send out signals through
secreted cytokines, which in turn have the ability to activate various pathogen fighting
cells (Janeway, 2001). The cells could be of the innate immune system, B-lymphocytes,
cytotoxic T cells, and nonimmune cells (Luckheeram, 2012). They also play a role in
suppression of immune reaction (Luckheeram, 2012). There are two commonly known
CD4+ T cell subtypes; T-helper 1 (Th1) and T- helper 2 (Th2) cells. Other CD4+ T
subtypes have been identified and include T-helper 17 (Th17), follicular helper T cell
(Tfh), induced T regulatory cells (iTreg), regulatory type 1 cells (Tr1) and T-helper 9
(Th9) (Luckheeram, 2012). Loss of CD4+ T cell function results in compromised
immune system, making the individual more susceptible to disease (Zhu, 2010).

T Cell Activation
For a T cell to differentiate, it must first become activated. In order to become
fully activated, the cell must complete three distinct activation signals (Goral, 2011). The
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three-signal hypothesis explains the necessary signals. T cell activation begins when an
antigen-presenting cell (APC) is introduced to an antigen (Roche, 2015). The APC
causes the foreign pathogen to be endocytosed and cleaved (Roche, 2015). Class II
major histocompatibility complex (MHCII) presents a portion of the antigen that a CD4+
T cell can then bind to. TCR and CD4 interaction with antigen-MHC II complex causes
antigenic stimulation (Goche, 2015). This is the first signal. TCR signaling induces a
network of downstream signaling that promote naïve cell proliferation and differentiation
into subtype lineages (Luckheeram, 2016). Costimulatory response is the required for
cell activation and is considered signal 2 (Goral, 2011). Costimulation of the T cell
occurs by APCs interaction with CD28. Signals provided by inflammatory cytokines are
required for an effective T Cell response, so cytokine signaling is signal 3 (Goral, 2011).
Naïve cells are then able to transform into specific T cell subtypes based on the
environmental factors. The Th2 cell is responsible for coordinating response to large
extracellular pathogens (Luckheeram, 2012).
Once T Cells have been activated, there is switch in metabolism for the cell
which can be referred to as metabolic reprograming (Almedia, 2016). Naïve cells are
quiescent, meaning they are not dividing, until receiving the activation signals (Pearce,
2013). The activation of the T cell requires a metabolic shift for the cell to grow and
divide (Almedia, 2016). Shifts in metabolism can be seen in a variety of areas. There is
an increased flux in glycolysis, glutaminolysis, pentose phosphate pathway, and the
hexoamine pathway (Almedia, 2016). There is a strong increase in glucose uptake,
making glucose readily available within the cells (Palmer, 2015). Naïve cells exhibit
oxidative phosphorylation, but activation results in aerobic glycolysis, also known as the

Lichter 6
Warburg Effect. The Warburg Effect is when the cell relies on glycolysis followed by
lactic acid fermentation as it’s source for energy (Pearce, 2013). Also, there is a switch
from fatty acid metabolism to fatty acid synthesis (Almedia, 2016). Fatty acids are basic
components of the plasma membrane and required when the cell is growing and
dividing.

Th2 Differentiation
Differentiation refers to the process by which a cell develops into specialize
subset of a specific cell allowing it to perform unique functions (Luckheeram, 2012).
Differentiation is influenced by environmental factors present, such as cytokines and
transcriptional factors (Luckheeram, 2012). For Th2, GATA3 is a transcription factor that
is the master regulator (Zhu, 2010). Without the presence of this transcriptional factor,
Th2 cells would not develop. In the absence of GATA3, naïve cells are diverted to Th1
cells (Zhu, 2010). Naïve cells in the presence of GATA3 are also responsible for the
suppression of Th1 differentiation by downregulating STAT4 (Zhu, 2010). Other
transcriptional factors that influence the differentiation of Th2 cells include STAT6,
STAT5, STAT3, Gfi-1, c-Maf, IRF4 (Jetten, 2009). GATA3 alone cannot form Th2 cells
(Zhu, 2012). The master regulator needs collaboration, specifically with STAT6. As
mentioned, cytokines play an influential role in the development of Th2 cells (Zhu,
2010). Important cytokines for Th2 differentiation include IL4 and IL2 (Jetten, 2009). IL2
activates STAT5 (Jetten, 2009).
Everything mentioned so far, helps with the development of Th2 cells, but there
are also elements that can prevent the differentiation of Th2 cells. Inhibitory
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transcription factors include T-bet and Runx3 (Zhu, 2010). Naïve cells in the presence
of these inhibitory transcription factors will prevent Th2 cells from developing (Zhu,
2010). Instead, the naïve cell will be diverted to another type of specialized T-cell. As
mentioned early, a metabolic reprogramming occurs when the T cells are activated. The
transcription factors mentioned are unique to each specific cell subtype and contribute
to the overall metabolism of the cell.

Computational Modeling
Computational models are built using experimental data, as well as known
characteristics of in vivo and in vitro systems. These models can be used to run
simulations that represent hypothetical situations. The simulations can lead to
predictions or hypotheses that can be tested with further simulations and experimental
data. Computational modeling aims to replicate a system based on known properties of
the system’s components (Brodland, 2015). Metabolic processes have a fundamental
role in many important aspects of human health. These processes are vastly complex
and the large number of cellular components and interactions can be hard to interpret.
Computational modeling is a way to make sense of these complex systems. These
models are based on conceptual, mathematical and algorithmic assumptions (Brodland,
2015). It allows the user to change environmental factors and observe their affects.
Constraint based modeling is a type of computational modeling. It is a
mathematical technique in which the outputs are limited based on a maximum and
minimum limit, or constraint (Haggart, 2011). This type of modeling is often paired with
optimization to determine the most optimal solution of an objective under the given
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constraints. Constraints reduce the possible solutions and allow for more accurate
predictions. Constraint based modeling is common technique used to create metabolic
network models. In metabolic network modeling, there are four commonly used
constraints. They include physico-chemical constraints, environmental constraints,
spatial/topological constraints, and self-regulatory constraints (Haggart, 2011).
More specifically, Flux Balance Analysis (FBA) is a type of constraint-based
modeling and will be used in the construction of the Th2 metabolic network. It is an
approach that analyzes flow of metabolites through a metabolic network based on
mathematics (Orth, 2010). This method allows for the prediction of growth rate and rate
of production of important metabolites (Orth, 2010). The metabolic network will contain
all known metabolic reactions in the organism and genes that code for each enzyme.
FBA predicts the flux profile that optimizes a defined objective without experimental
measurements (Orth, 2010). It assumes that cellular metabolism is in a steady-state
and uses linear programing to the determine the flux-profile that optimizes the
organism’s objective function (Orth, 2010). Typically, the objective is biomass
production and that is what the objective will be for the Th2 metabolic network.
The program MatLab will be used to construct the Th2 metabolic network model.
Recon2.2.05, an extensive map of all genes in the human genome, will be used as the
seed model upon which the Th2 model will be created. Recon2.2.05 is the most
representative model of human metabolism to date (Swainston, 2016). It differs from
previous versions in that there have been significant updates to respecification of fatty
acid metabolism, oxidative phosphorylation and a coupling of the electron transport
chain to ATP synthase activity (Swainston, 2016). The model was developed through a
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combination of manual and automated error checking. This version of the model
contains 5324 metabolites, 7785 reactions, and 1675 associated genes (Swainston,
2016).

Methods
Obtaining Expression Data Sets
Gene Expression Omnibus (GEO), a public data base containing gene sets, was
used to search for untreated differentiated Th2 cells. When searching for datasets,
unpolarized subtype conditions and subtype controls were accepted and used in the
model. Knock out and treated cells were excluded from sample gathering. Both
technical and biological replicates were used in the construction of the models. Three
types of expression datasets were included in the models. These platforms were
Affymetrix, Agilent, and Proteomics. A complete list of samples can be found in Table 1.

Sample
GSM60357
GSM60358
GSM60362
GSM60368
GSM60373
GSM60379
GSM60708
GSM60709
GSM60713
GSM60719
GSM60724

Source
cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells

Th2 Samples (37)
Treatment
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4

Time
2 hours
6 hours
48 hours
48 hours
6 hours
2 hours
2 hours
6 hours
48 hours
48 hours
6 hours

Replicate
1a
1a
1b
2b
2a
2a
1a
1a
1b
2b
2a

GSM60730
GSM60742
GSM60743
GSM60747
GSM60753

cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells
cord blood CD4+ cells

antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4

2 hours
2 hours
6 hours
48 hours
48 hours

2a
1a
1a
1b
2b
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GSM60758
GSM60764
GSM565281
GSM565282
GSM565283
GSM565284

cord blood CD4+ cells
cord blood CD4+ cells
CD4+ t cells, PBMC
CD4+ t cells, PBMC
CD4+ t cells, PBMC
CD4+ t cells, PBMC

antiCD3+andtiCD28+IL4
antiCD3+andtiCD28+IL4
aCD3/aCD28
aCD3/aCD28
aCD3/aCD28
aCD3/aCD28

6 hours
2 hours
12 hours
12 hours
12 hours
48 hours

2a
2a
1
2
3
1

GSM565285
GSM565286
GSM565998

CD4+ t cells, PBMC
CD4+ t cells, PBMC
CD4+ t cells, PBMC

aCD3/aCD28
aCD3/aCD28
aCD3/aCD28

48 hours
48 hours
12 hours

2
3
1

GSM565999
GSM566000
GSM566001
GSM566002
GSM566003
GSM1070756

CD4+ t cells, PBMC
CD4+ t cells, PBMC
CD4+ t cells, PBMC
CD4+ t cells, PBMC
CD4+ t cells, PBMC
naïve CD4+ t cells
isolated from
peripheral blood
naïve CD4+ t cells
isolated from
peripheral blood
naïve CD4+ t cells
isolated from
peripheral blood
Whole blood
Whole blood
Whole blood
Whole blood

aCD3/aCD28
aCD3/aCD28
aCD3/aCD28
aCD3/aCD28
aCD3/aCD28
Activated with
PMA/Ionomycin for 4 hours

12 hours
12 hours
48 hours
48 hours
48 hours
28 days

2
3
1
2
3
1

Activated with
PMA/Ionomycin for 4 hours

28 days

2

Activated with
PMA/Ionomycin for 4 hours

28 days

3

GSM1070760

GSM1070764

GSM1054776
GSM1054784
GSM1054788
GSM1054792

2
3
1
4

Table 1: Th2 Samples
A summary of the thirty-seven samples used to create the Th2 metabolic model is
contained in the table. Sample name, source, treatment, replicate can be found on the
table.

Expression Data Analysis
Affymetrix data was analyzed by downloading the raw expression sets from the
GEO database or from the literature. Using the Affy package in R, MAS5.0
normalization was applied to the data to compensate for systematic technical
differences between chips. Through normalization, expression of a probes was
designated as present, marginal or absent. These are referred to as PMA calls. A
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present or marginal signal represents an active gene. An absent signal represents an
inactive probe. A probe was considered active if at least half of the samples for the
probe were deemed active. A probe was determined to be inactive if less than half of
the samples for the probe were deemed active. Affymetrix datasets used in the model
were GSE2770, GSE22886, and GSE43769.
One Agilent dataset, GSE43005, was used to create the metabolic network
model. This dataset was quantile normalized and averaged over the four biological
replicates. A control probe was used in this experiment. The average expression of the
four samples for a single probe was compared to the average expression for the control
probe. If the expression level was greater than the control, then the probe was
considered active. If the expression level fell below the level of the control, the probe
was marked as inactive.
A proteomics data set was obtained from literature. Genes of measured proteins
were deemed active if at least half the samples had a protein count greater than zero.
Genes of proteins were deemed inactive if at least half the samples had no protein
counts present.

Final Expression Determination
The final expression for the genes was determined by combining all datasets. To
do this, R was used to combine the expression sets into one dataset containing all
probe ids and samples from the microarray data. Probe ids were converted into HGNC
ids. Samples had been previously marked with a one or zero; one indicating active and
zero indicating inactive genes. For each HGNC id, the samples were averaged. If the
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average across the samples was greater than 0.5, the gene was considered active. If
the average was less than 0.5, then the gene was inactive.
The active probes in the microarray and proteomics data were compared. The
overlapping genes between the two types of data are considered high-confidence active
genes. These are used in the final model. The same process was used to determine
inactive genes used in the model. To further curate the data and account for genes that
may not have been measured in the microarray data or vice versa, further analysis of
both proteomics and microarray data was conducted. For the proteomics data, the
average raw count for each HGNC id was calculated across the four samples. Using the
quartile function, genes with the protein counts in the 75th percentile were determined.
These genes were considered active regardless of whether they overlapped with the
microarray. Genes in the 25th or lower percentile were considered inactive and added to
the final model. For the microarray data, genes from the non-overlap between
microarray and proteomics with 90 percent or greater active samples were added as
active genes to the final model. Microarray genes from the non-overlap area with 10%
or less active samples were added to the model as inactive genes. The final expression
matrix consisted of HGNC ids represented as active (1) or inactive (0). These
expression values were then used to create the metabolic model.

Metabolic Network Model Generation
The metabolic model was created using the COBRA Toolbox in Matlab. The
function createTissueSpecificModel was used for model construction. Recon2.2.05 was
used as the seed model and the matrix created from the microarray and proteomics
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data was used as the expression data. The removeDeadEnds function was used to
remove any unnecessary metabolites and reactions. The model was then ready for
further analysis.

Validation of Model
The model was further analyzed to determine its validity. These validations
included determination of the biomass function, gene essentiality, flux through major
metabolic pathways, and model response to removal of glucose or glutamine. Using the
function optimizeCbModel, the biomass function was determined. This value was
compared to published values for humans to see if the results aligned. Gene essentiality
was determined in the model with the function [GrRatio, GrRatioKO, grRatioWT,
delRxn, hasEffect] = singleGeneDeletion(model). Cobra solver gurobi was used.
Essential genes in the model were compared to the essential genes of other human cell
types. A list of essential human genes in other cell types has been published in the
Online GEne Essentiality (OGEE) database. Flux through glycolysis, fatty acid
synthesis, fatty acid oxidation, and the tricarboxylic acid cycle (TCA) pathways were
determined. Lastly, removal of glucose or glutamine transport reactions was done using
removeRxns(model, 'EX_gln_L(e)') for glutamine and removeRxns(model, 'EX_glc(e)')
for glucose.
Validation had two outcomes; a functional or a nonfunctional model. A functional
model had validation results that aligned with expected and known result of actual Th2
cells. A nonfunctional model had validation results that were not what was expected.
When it was determined that the model was nonfunctional, the model needed to be
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edited. Models were edited to adjust them to the proper expected results. Model
refinements included changing the biomass objective function, addition and removal of
reactions, adjustment of reaction bounds, and fixing errors related to syntax.

Results
Final Gene Expression Determination
The final gene expression was determined by combining the expression datasets
obtained from the GEO database. When comparing the active genes from the
microarray data to the active genes from the proteomics data, there were 6619 active
genes that overlapped. These genes were considered high-confidence active genes
and were put into the final model (Fig. 1). Of the 958 proteomics genes that did not
overlap with the microarray data, 149 were in the top 75th percentile of expression levels
of all proteomics genes and added to the final model (Fig. 2). Looking at the microarray
data, 6913 active genes did not overlap with the proteomics data. 103 of the nonoverlapping active microarray genes were in the top 10% of expression rates and added
the final matrix (Fig. 3). As for inactive genes, 1378 genes were determined to be both
inactive in the proteomics data and the microarray data (Fig. 4). Of the non-overlapping
region, there were 833 inactive genes from the proteomics data that were in the bottom
25th percentile and added to final model (Fig. 5). There were 2937 inactive genes added
to the final model from the microarray data that represents the bottom 10% of
expression levels (Fig. 6). Table 2 summarizes the matrix composition.
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Figure 1: High Confidence Active Genes
The active genes from the microarray data (Active Affy) were compared to the active
genes from the proteomics data (Active Prot). The overlap represents genes that were
active in both types of data and are considered high-confidence active genes.

Figure 2: Added Active Proteomics Genes
Active genes from the Proteomics data that did not overlap with the microarray data
(Fig.1) were compared to the top 75th percentile of active proteomics genes. The
overlap represents genes that are not present or active in the microarray but fall in the
top 75th percentile of active gene in the proteomics data.
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Figure 3: Added Active Microarray Genes
Genes from the microarray data that did not overlap with the proteomics data (Fig.1)
were compared to the top 10% of active genes from the microarray data. The overlap
represents genes that were not present or active in the proteomics data but were in the
top 10% of active microarray genes.

Figure 4: High-Confidence Inactive Genes
The inactive genes from the microarray data (Inactive affy) were compared to the
inactive genes from the proteomics data (Inactive prot). The overlap represents genes
that were not active in either of the two data sets and are considered high confidence
inactive genes.
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Figure 5: Added Inactive Proteomics Genes
Inactive genes from the Proteomics data that did not overlap with the microarray data
(Fig.3) were compared to the bottom 25th percentile of inactive proteomics genes. The
overlap represents genes that are not present or inactive in the microarray data, but fall
in the bottom 25th percentile of inactive gene in the proteomics data.

Figure 6: Added Inactive Microarray Genes
Genes from the microarray data that did not overlap with the proteomics data (Fig.1)
were compared to the top 10% of active genes from the microarray data. The overlap
represents genes that were not present or active in the proteomics data but were in the
top 10% of active microarray genes.
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Th2 Matrix Composition
Active Genes in Both Microarray and
Proteomics
Active Proteomic Genes Added

6619

Active Microarray Genes Added

103

Inactive Genes in Both Microarray and
Proteomics
Inactive Proteomics Genes Added

1378

Inactive Microarray Genes Added

2937

149

822

Table 2: Th2 Model Composition
This table summarizes the results of the Th2 Matrix used to construct the final model.
Sources for the active and inactive genes are listed.

Th2 Metabolic Model
The final Th2 model consisted of 1151 genes, 2601 metabolites, 4654 reactions.
The biomass objective function was 1.7037/hour. Table 3 summarizes these results.
Because the model was based off Recon2.2.05, all reactions, genes, and metabolites
present in the Th2 metabolic network, were also present in the Recon2.2.05 metabolic
model. Essentially, the Th2 metabolic model constructed represents a subset of the
Recon2.2.05 model.
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Th2 Model
Genes

1151

Metabolites

2601

Reactions

4654

Biomass Objective Function

1.7037/hour

Table 3: Th2 Model Composition
This table summarizes the results upon curation of the Th2 metabolic model. You can
find number of genes, reactions, and metabolites, as well as the biomass objective
function.

Model Validations
The model was analyzed to determine the validity. When model validations were
consistent with what was expected, the model was considered valid. When the
validations did not align with the expected outcomes, the model was considered
nonfunctional. The nonfunctional models needed to be edited so that it would reflect the
expected results. The Th2 metabolic model required a change in biomass objective
function. The original biomass objective function was a series of functions for individual
compartments. This was replaced with one biomass object function that was
representative of the system. Change in the biomass objective function required the
addition of reactions to support the new objective function and removal of reactions
associated with old biomass objective function. The reaction bounds were changed for
some of the reactions. This was due to some reactions being limited to only one
reaction direction. Bounds were changed to allow forward and reverse direction. There
were syntax errors in the model, which caused it to be nonfunctional. Correcting these
errors was essential.
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The model was first optimized, which resulted in a biomass reaction flux of
1.7037/hr. This was determined to be within reason of an appropriate value for the Th2
model. The biomass function is a representation of cell growth or biomass production.
So, a biomass value of 1.7037 means the cell has a biomass production, or cell growth,
of 1.7037 per hour.
Next, gene essentiality was determined. It was determined that Th2 has 49
essential genes. This was determined by looking at the knockout gene ratio. When the
biomass value was decreased to zero, this indicated that the gene was essential
because deletion of the gene resulted in no biomass production. The essential genes
were then compared to essential genes in other human cell types. As mentioned earlier,
a list of essential human genes was obtained from OGEE database. Of those 49
essential Th2 genes, 38 of them were determined to be essential in other human cell
types as well.
Flux through the major metabolic pathways was next determined. Each reaction
involved in glycolysis and the TCA cycle was checked. Flux through these pathways
indicates flow of metabolites and the reactions in the pathways are active, or occurring.
There was an overall flux through these pathways. Reactions associated with fatty acid
synthesis and fatty acid oxidation were also determined to have flux through their
pathways.
Last, the glucose exchange reaction was removed from the model. This resulted
in a decrease in the biomass flux reaction. The reaction decreased from 1.7037
biomass production per hour to 1.5867 biomass production per hour. When glutamine
was removed, a decrease in biomass flux reaction was also observed. The value
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decreased from 1.7037 biomass production per hour to 1.6168 biomass production per
hour.

Discussion
We have successfully constructed a functional metabolic model for Th2. Upon
analysis of the model, we can determine the validity of it. Looking at the biomass
objective function serves an important function in determining the growth rate of an
organism. Through flux balance analysis we can determine this. Flux balance analysis
calculates the flow of metabolites through the metabolic network (Feist, 2010). It
describes the growth requirements of a cell and can give insight to the cellular
processes occurring within the cell. The Th2 model had a growth rate of 1.7037/hr. This
means that the cell has a 0.587 hour doubling time. We considered these reasonable
for a Th2 cell by comparing them to published growth rate values. A low biomass
objective function would indicate low cell growth and biomass production. Because Th2
cells are actively growing and dividing, this biomass function is expected.
We also looked at gene essentially within the Th2 model. The
singleGeneDeletion function works by removing a single gene from the model and
representing the result of deletion with a biomass objective function value. A decrease
in this value indicates the gene’s importance to the model. A biomass value that drops
to zero upon the deletion of a gene signifies that the model is unable to grow without
that gene. Unchanged biomass function, indicates that when the gene was deleted
there was no effect on the biomass production of the cell and that gene would not be
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considered essential. The cell can still survive without that gene. It was determined that
there were 49 essential genes specific to this model. When comparing those essential
genes to the known essential genes in other human cell types, 38 of the 49, or 77.6%,
genes were also essential in other human cell types. We expected there to be a high
number of essential genes in our model that were also essential other human cells.
Many of the essential metabolic pathways in other human cell types are also present in
our model.
Both glucose and glutamine are important for proper functioning of Th2 cells.
Glucose is used for ATP generation. Glucose is transported into the cell by GLUT1,
which is the major glucose transporter for T cells (Porter, 2015). Glucose becomes
trapped inside the cell and is metabolized through glycolysis to produce pyruvate and
two ATP molecules (Porter, 2015). Pyruvate can be further oxidized through the TCA
cycle, which will fuel the oxidative phosphorylation pathway and produce 36 ATP
molecules (Palmer, 2015). Glutamine is important for T cells activation and growth. After
T-cell activation, glutamine catabolism is dramatically induced (Van der Windt, 2012).
Glutamine can be used for glutaminolysis, to maintain homeostasis of TCA cycle or to
generate NAD and NADH (Kouidhi, 2017). It can also be used during T cell activation to
overcome intense aerobic glycolysis (Kouidhi, 2017). Glutamine can do this by providing
pyruvate. Lack of glutamine can result in inhibition of cell growth, proliferation, and
cytokine production (Palmer, 2015). The importance of glucose and glutamine to the
Th2 model system can be demonstrated by observing the effect of removing either of
these substrates from the model on the biomass objective function. Because both
glucose and glutamine play crucial roles in Th2 cell metabolism, we would expect the
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biomass objective function to be negatively affected. Upon removal of either from the
cell, we observed a decrease in the biomass function. This indicates slowed growth,
agreeing with what would be observed in nature. The reason we didn’t see the biomass
objective function drop to zero upon removing glucose or glutamine is because there
are other carbon sources available that the cell can use for metabolism.
Furthermore, glycolysis, TCA cycle, fatty acid synthesis, and fatty acid oxidation
are important metabolic processes for a Th2 cell (Pearce, 2013). By analyzing these
pathways, we can determine if the model is behaving in the way we expect it to. The
individual reactions of each metabolic process were looked at to determine if there was
flux. Flux indicated that the reactions were occurring. While not every reaction in the
pathway had flux, every metabolic process had an overall flux signifying that the
process was active. This is what we would expect and serves as further validation of the
model. Lack of specific flux could indicate equilibrium of the specific reaction.

Conclusion
We have constructed a Th2 specific metabolic model using gene expression
data. The final model was built off Recon2.2.05 and contains 1151 genes, 2601
metabolites, and 4654 reactions. As our team continues to do research, the model will
become further validated. Eventually we hope to create a Th2 model that is true to how
Th2 cells function in the human immune system. Naïve subtype cells Th1, Th17 and
Treg have also been constructed. This type of model can give insights into how the
immune system reacts to different pathogens, cytokines, and environmental stimulants
by simulation of the model. These models have applications in education, technology,
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and medicine. Eventually, we hope to use these models to look at differences between
the subtype naïve cells to gain a better understanding of the unique metabolic
processes associate with each subtype cell. Beyond furthering our own research, these
models will be shared with the scientific community and can further the research of
others.
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